Jun 16, 2020
CANbridge Pharmaceuticals Appoints Senior Vice President/Global Head of Business Development
Jun 12, 2020
EHA25Virtual: A New Paradigm in Relapsed Refractory Hodgkin Lymphoma
Jun 11, 2020
Celltrion’s Subsidiary Acquires Primary Care Product Assets for Asia Pacific Markets from Takeda Pharmaceutical Company Limited
Apr 09, 2020
PHA121, the first orally available bradykinin B2-receptor antagonist, shows clinically relevant activity in a translational in vivo model
Apr 01, 2020
The Leukemia & Lymphoma Society And Partners Commit $4.5 Million For Blood Cancer Patients Impacted By COVID-19
Mar 31, 2020
Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020
Mar 25, 2020
Juntendo University Research: A New Combination Therapy is Effective in Treating a Rare Blood Cancer Cell Type
Jan 15, 2020
Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop Next-Generation Cell Therapy Products
Dec 19, 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Dec 06, 2019
Multiple Myeloma Research Foundation (MMRF) Continues to Accelerate Discoveries and Breakthroughs
Oct 28, 2019
Prometheus Biosciences Strengthens Executive Management Team With New Appointments
Sep 17, 2019
Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019
Aug 05, 2019
Sosei Heptares and Takeda Enter Into New Strategic Multi-target Research, Development and Commercialization Partnership
Jul 08, 2019
EIP Pharma Appoints Noel Donnelly as CFO
Jul 02, 2019
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
Jun 19, 2019
Global Hereditary Angioedema (HAE) Markets, 2017-2018 & 2019-2026
Jun 14, 2019
New Data Presented at 24th EHA Congress From Oncopeptides' Phase 1/2 ANCHOR Trial Evaluating Melflufen in Relapsed/Refractory Multiple Myeloma (RRMM)
Jun 04, 2019
Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics, to improve a novel intracellular delivery technology
May 08, 2019
Curadev Announces Licensing Agreement With Takeda for Novel STING Agonist
May 07, 2019
Armas Pharmaceuticals Continues to Add to Portfolio With Launch of Second Oncology Injectable